Aminoglycosides Flashcards
What formulations are aminoglycosides given for systemic infections?
IM or IV
Nephrotoxicity Risk Factors
Increased Age Preexisting renal insufficiency Hypovolemia Using other nephrotoxic agents Liver disease
What are some other nephrotoxic agents?
Amphotericin B
Furosemide
Vancomycin
Contrast dye
Things you need to monitor while a patient is on aminogylcoside therapy?
Serum Creatinine
Liver enzymes/funtion
(BUN and Creatinine)
What are normal Serum creatinine levels?
0.6-1.2 mg/dL
What toxicities are you watching out for when you give a patient aminoglycosides?
Nephrotoxicity (reversible)
Ototoxicity (irreversible)
Medications that are risk factors for ototoxicity
Loop diuretics
Vancomycin
Where do aminoglycosides distribute?
Extracellular fluids (~25% of body weight) (0.25L/kg)
Not in fat, meninges, etc.
What do you expect the volume of distribution of neonates and newborns to be of aminoglycosides?
I expect it to increase because they have more water/extracellular fluid.
How long do we infusion IV?
30 minutes to 1 hour
Is the protein binding high or low?
Low (10%)
What model are the aminoglycosides (one, two, or three compartment)?
Three compartment, but treat as one.
Has Distribution, accumulation, and elimination phases.
Why do we draw our peak levels 30 minutes before and after infusions?
To ignore the distribution phase and elimination phases. This allows us to treat the aminoglycosides as one compartment.
How long does it take you to get to steady state?
3-5 half-lives
What drives dose?
Volume of distribution
What does renal function (creatinine clearance) drive?
Half-life